Proceedings: Inhibition of hepatic gluconeogenesis by salicylate.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005420:Flavoproteins / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007659:Ketones / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000378:metabolism; D009392:Nephrectomy; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D011742:Pyrimidine Nucleotides / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*
D001786:Blood Glucose; D005420:Flavoproteins; D007659:Ketones; D011742:Pyrimidine Nucleotides; D011773:Pyruvates; D012459:Salicylates; D005947:Glucose